151 related articles for article (PubMed ID: 33124483)
21. Controlled release of an endostatin peptide using chitosan nanoparticles.
Ebrahimi Samani S; Seraj Z; Naderimanesh H; Khajeh K; Esmaeili Rastaghi AR; Droudi T; Kolivand P; Kazemi H; Asghari SM
Chem Biol Drug Des; 2017 Sep; 90(3):417-424. PubMed ID: 28165672
[TBL] [Abstract][Full Text] [Related]
22. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines.
Nayak D; Minz AP; Ashe S; Rauta PR; Kumari M; Chopra P; Nayak B
J Colloid Interface Sci; 2016 May; 470():142-152. PubMed ID: 26939078
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of amygdalin-loaded alginate-chitosan nanoparticles as biocompatible drug delivery carriers for anticancerous efficacy.
Sohail R; Abbas SR
Int J Biol Macromol; 2020 Jun; 153():36-45. PubMed ID: 32097740
[TBL] [Abstract][Full Text] [Related]
24. Preparation, Characterization, and Anticancer Activity Assessment of Chitosan/TPP Nanoparticles Loaded with
Kancha MM; Mehrabi M; Bitaraf FS; Vahedi H; Alizadeh M; Bernkop-Schnürch A
Anticancer Agents Med Chem; 2024; 24(7):533-543. PubMed ID: 38243949
[TBL] [Abstract][Full Text] [Related]
25. Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design.
Petkar KC; Chavhan S; Kunda N; Saleem I; Somavarapu S; Taylor KMG; Sawant KK
AAPS PharmSciTech; 2018 May; 19(4):1758-1772. PubMed ID: 29589222
[TBL] [Abstract][Full Text] [Related]
26. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Almutairi FM; Abd-Rabou AA; Mohamed MS
Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
[TBL] [Abstract][Full Text] [Related]
27. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
28. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide.
Irani M; Mir Mohamad Sadeghi G; Haririan I
Int J Biol Macromol; 2017 Apr; 97():744-751. PubMed ID: 28109815
[TBL] [Abstract][Full Text] [Related]
29. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
Miao Y; Qiu Y; Yang W; Guo Y; Hou H; Liu Z; Zhao X
Colloids Surf B Biointerfaces; 2018 Sep; 169():313-320. PubMed ID: 29800906
[TBL] [Abstract][Full Text] [Related]
30. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
[TBL] [Abstract][Full Text] [Related]
31. Polyelectrolyte three layer nanoparticles of chitosan/dextran sulfate/chitosan for dual drug delivery.
Wang F; Li J; Tang X; Huang K; Chen L
Colloids Surf B Biointerfaces; 2020 Jun; 190():110925. PubMed ID: 32155455
[TBL] [Abstract][Full Text] [Related]
32. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of chitosan nanoparticles loaded with greater celandine (Chelidonium majus L.) essential oil as an anticancer agent on MCF-7 cell line.
Hesami S; Safi S; Larijani K; Badi HN; Abdossi V; Hadidi M
Int J Biol Macromol; 2022 Jan; 194():974-981. PubMed ID: 34856216
[TBL] [Abstract][Full Text] [Related]
35. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
Belgamwar A; Khan S; Yeole P
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):374-386. PubMed ID: 28423949
[TBL] [Abstract][Full Text] [Related]
36. Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells.
Jiang J; Liu Y; Wu C; Qiu Y; Xu X; Lv H; Bai A; Liu X
Drug Dev Ind Pharm; 2017 Aug; 43(8):1304-1313. PubMed ID: 28402175
[TBL] [Abstract][Full Text] [Related]
37. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of β-boswellic acid based HDAC inhibitors as inducers of cancer cell death.
Sharma S; Ahmad M; Bhat JA; Kumar A; Kumar M; Zargar MA; Hamid A; Shah BA
Bioorg Med Chem Lett; 2014 Oct; 24(19):4729-4734. PubMed ID: 25176189
[TBL] [Abstract][Full Text] [Related]
39. Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90.
Matokanovic M; Barisic K; Filipovic-Grcic J; Maysinger D
Eur J Pharm Sci; 2013 Sep; 50(1):149-58. PubMed ID: 23583203
[TBL] [Abstract][Full Text] [Related]
40. 11-Keto-boswellic acid derived amides and monodesmosidic saponins induce apoptosis in breast and cervical cancers cells.
Csuk R; Barthel-Niesen A; Barthel A; Schäfer R; Al-Harrasi A
Eur J Med Chem; 2015 Jul; 100():98-105. PubMed ID: 26073487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
